Take part in the 5th edition of the Transatlantic Exchanges
Held on March 27, this fifth edition of the Transatlantic Exchanges will focus on “Transatlantic Innovations in Cancer Drug Research”. Registration is now open to attend the event either in person or via videoconference.
The Transatlantic Exchanges are the result of a partnership between Gustave Roussy and the Dana-Farber Cancer Institute, with the support of the Institut Servier. This annual meeting is dedicated to the latest advances in oncology and has been held alternately in Boston and Paris since 2022.
This 5th edition, entitled “Transatlantic Innovations in Cancer Drug Research” will take place on March 27 in Boston. International experts will focus their presentations on epigenetic therapies, microbiome-driven immunity and cellular pathway reprogramming.
These three areas of research illustrate how emerging technologies and innovative approaches are reshaping oncology worldwide through high-level collaborations.
- Epigenic therapies do not aim to alter genes themselves, but rather to regulate their activity, preventing cancer cells from exploiting certain mechanisms to grow.
- Microbiome-driven immunity seeks to understand how the billion of bacteria living in our gut influence the immune system and can enhance the effectiveness of cancer treatments.
- Cellular pathway reprogramming involves blocking or redirecting the internal circuits of cancer cells that enable them to survive, proliferate, or resist treatment.
Professor Laurence Albiges, Head of the Department of Medical Oncology at Gustave Roussy and an international expert in kidney cancer, will co-chair this fifth edition of the Transatlantic Exchanges alongside Professor Toni Choueiri, Director of the Lank Center for Genitourinary Oncology and Medical Director for International Strategic Initiatives at the Dana-Farber Cancer Institute.
Professor Fabrice Barlesi, CEO of Gustave Roussy, and Dr. Laurie Menger, Group Leader of the “Advanced cell therapies” research team at Gustave Roussy, will also take part as moderators.
Registration open
Registration to attend the event, either in person in Boston or remotely, is open to healthcare professionals interested in oncology: